Biotechnology

The New Multi Capsule "Medspresso Torro" Gets Unleashed

November 4, 2021 9:00 AM

CAPE TOWN, SA / ACCESSWIRE / November 4, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and mental health therapeutic research is pleased to share the following update: Medspresso™ is pleased to announce the launch of the new Medspresso™ Torro Dual Purpose Home Espresso Maker. The new design is unique in that it's one of very few capsule systems...

Read more

Pressure BioSciences’ BaroFold Platform Unleashes Hidden Growth Engine as Strong Demand for Protein Therapeutics Leverages PBI’s Protein Refolding Technology

November 4, 2021 8:55 AM

Titans and Emerging Leaders of Biopharma Struggling with Protein Misfolding and Aggregation Issues that Threaten Enormous Revenue Potentials Are Turning to PBI's Uniquely Enabling BaroFold Solution REMINDER: PBI to Participate in the Benzinga Virtual ALL ACCESS Investor Event Today at 11:20 am ET. SOUTH EASTON, MA / ACCESSWIRE / November 4, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and...

Read more

Edesa Biotech Extends COVID-19 Clinical Study to Poland

November 4, 2021 8:00 AM

Expansion to European Union country follows favorable Phase 2 results Company focusing on critically ill hospitalized patients TORONTO, ON / ACCESSWIRE / November 4, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that Polish regulators have approved a clinical trial application for the investigational use of the company's monoclonal...

Read more

Black Bird Biotech Releases Preliminary Findings from 4-Month MiteXstream(TM) Efficacy Testing; Strong Efficacy Results Clear Company for California Clearance Application

November 3, 2021 8:58 AM

FLOWER MOUND, TX / ACCESSWIRE / November 3, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, announced today that its independent testing lab, Botanical Research in Motion, Inc. (BRIM), a British Columbia-based botanical research firm, had released the preliminary findings of its four-month long multi-faceted study of its EPA-registered MiteXstreamTM biopesticide. "We found conclusive...

Read more

Lexaria Announces Ambitious New Hypertension Study HYPER-H21-4

November 3, 2021 7:30 AM

DehydraTECH-CBD also being evaluated in three other human clinical studies Positive studies would support Lexaria's regulatory approval plans KELOWNA, BC / ACCESSWIRE / November 3, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces a significant new study to expand its hypertension clinical program and provides updates on three ongoing human clinical...

Read more

Pressure BioSciences to Participate in the Benzinga ALL ACCESS Investor Event

November 2, 2021 9:37 AM

Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Live, Virtual Guest Appearance on Thursday, November 4, 2021 SOUTH EASTON, MA / ACCESSWIRE / November 2, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" and the "Company"), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide life sciences,...

Read more

Pieris Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Update

November 2, 2021 7:00 AM

Company To Host an Investor Conference Call on Tuesday, November 2, 2021 at 8:00 AM EDT Dosing completed in part 1a of phase 2a study of PRS-060/AZD1402 Dosing to begin this quarter in phase 2 study of cinrebafusp alfa Received regulatory approval from multiple countries for phase 1/2 study of PRS-344/ S095012 Presented preclinical data for PRS-220 at ERS; on track for 2022 clinical initiation Initiated second costim bispecific program in Seagen...

Read more

CB Scientific Announces Addition of Brooke Martellaro as Chief Financial Officer

November 2, 2021 6:00 AM

Seasoned finance executive and business leader to add significant incremental competencies to the Company's executive management team ESCONDIDO, CA / ACCESSWIRE / November 2, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") is a provider of remote ECG cardiac monitoring products and services; simple wearable solutions for detecting potentially life-threatening heart arrhythmias in patients with heart-related issues, both...

Read more

Helix BioPharma Corp. Provides Bi-Weekly MCTO Status Update

November 1, 2021 7:00 PM

RICHMOND HILL, ON / ACCESSWIRE / November 1, 2021 / Helix BioPharma Corp. (TSX:HBP) ("Helix" or the "Company"), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is providing this bi-weekly update on the status of the management cease trade order granted on November 1, 2021 (the "MCTO") by its principal regulator, the Ontario Securities Commission under National Policy 12-203 Management...

Read more

Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET

November 1, 2021 4:01 PM

AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial results for the third quarter ended September 30, 2021 and recent corporate highlights. Third Quarter 2021 Selected Financial Results Total revenue of $16.4 million, an increase of 28% compared to the third quarter of 2020...

Read more

Mosaic ImmunoEngineering's Lead Immuno-Oncology Candidate MIE-101 Highlighted in Keynote Presentation

November 1, 2021 10:20 AM

- Nanoparticle technology shown to be effective in transforming immunologically "cold" tumors to "hot" - - Data presented support durable antitumor activity - NOVATO, CA / ACCESSWIRE / November 1, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious...

Read more

Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System

November 1, 2021 9:30 AM

Study demonstrates high success rates, ease of use, and economic value in the treatment of GI defects AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced the publication of a multi-center study of the X-Tack®System in closing challenging gastrointestinal defects. Removal of gastrointestinal...

Read more

Lexaria Announces R&D Program to Compare First and Only FDA-Approved Prescription Cannabidiol

November 1, 2021 9:00 AM

New study EPIL-A21-1 will compare effectiveness of FDA-approved Epidiolex to DehydraTECHTM-CBD for reducing seizure activity KELOWNA, BC / ACCESSWIRE / November 1, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, has commenced an important new study exploring whether DehydraTECHTM-CBD evidences superior ability to inhibit seizure activity compared to both...

Read more

Medspress(TM) Announces Webinar: The Art, Craft, and Science of Coffee

November 1, 2021 8:00 AM

CAPE TOWN, SA / ACCESSWIRE / November 1, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("WGG'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update: Medspresso™ is pleased to announce its live coffee webinar is scheduled for Friday, 12 November 2021 at 15:00 SAST. The webinar will feature a panel of coffee experts with decades' worth...

Read more

Biophytis to Report Restated Financial Statements for Previous Periods and as of June 30, 2021

October 29, 2021 2:55 AM

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 29, 2021 / Biophytis SA (NASDAQ:BPTS)(Euronext Growth Paris:ALBPS) (the "Company" or "Biophytis"), a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, including severe respiratory failure in patients suffering from...

Read more

EV Biologics Chief Medical Officer Publication on COVID-19 & Exosomes

October 28, 2021 10:00 AM

NASHVILLE, TN / ACCESSWIRE / October 28, 2021 / EV Biologics Corp, OTC Pink:YECO, today updated shareholders about a recent publication authored by its Chief Medical Officer, Dr. Jason Sanders. This review discusses some of the cellular and molecular pathology of COVID-19 and the relevant therapeutic mechanisms of small extracellular vesicles (EVs), such as exosomes, in Acute Lung Injury (ALI). The original manuscript was initially prepared by...

Read more

CB Scientific, Inc. Appoints Paul Danner as Chairman

October 28, 2021 6:00 AM

The addition marks the first in a series of executive leadership enhancements intended to position CBSC for accelerated success ESCONDIDO, CA / ACCESSWIRE / October 28, 2021 / CB Scientific, Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") is a provider of remote ECG cardiac monitoring products and services; simple wearable solutions for detecting potentially life-threatening heart arrhythmias in patients with heart-related issues, both...

Read more

RepliCel Announces DermaPrecise Trademark for Dermal Injector Product Line

October 28, 2021 6:00 AM

Trademark registrations kickoff pre-commercial planning VANCOUVER, BC / ACCESSWIRE / October 28, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, announced today the DermaPrecise trademark for its dermal injector product portfolio. "The DermaPrecise Injector is an electronic injection system which will bring new...

Read more

Invitation to Presentation of BioInvent’s Interim Report January–September 2021

October 28, 2021 2:30 AM

LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV) Lund, Sweden, October 28, 2021 - BioInvent International AB (Nasdaq Stockholm: BINV) invites to a presentation of the third quarter report 2021 and a telephone conference with CEO Martin Welschof. The presentation will be held in English. When: 2:00 p.m. CEST Thursday October 28, 2021. Listen to the presentation: https://tv.streamfabriken.com/bioinvent-q3-2021 To...

Read more

BioInvent International AB Interim Report January - September 2021

October 28, 2021 2:30 AM

LUND, SWEDEN / ACCESSWIRE / October 28, 2021 / BioInvent International (STO:BINV) "The powerful combination of BioInvent's R&D and in-house manufacturing provides invaluable support to our clinical development and facilitates the execution of our current clinical portfolio. The integration of functions, on top of world leading science, makes it possible for us to develop novel treatments for patients suffering from serious diseases. The solid...

Read more